AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + Vehicle
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Distal, Subungual Onychomycosis
Conditions
Distal, Subungual Onychomycosis
Trial Timeline
Jun 30, 2006 → Aug 31, 2007
NCT ID
NCT00679770About AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + Vehicle
AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + Vehicle is a phase 2 stage product being developed by Pfizer for Distal, Subungual Onychomycosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00679770. Target conditions include Distal, Subungual Onychomycosis.
What happened to similar drugs?
0 of 1 similar drugs in Distal, Subungual Onychomycosis were approved
Approved (0) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00679770 | Phase 2 | Completed |
Competing Products
2 competing products in Distal, Subungual Onychomycosis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + AN2690 Solution Vehicle | Pfizer | Phase 2 | 35 |
| ADV7103 + Placebo | Advicenne | Phase 3 | 22 |